Distinguishing Primary Progressive Aphasia Subtypes: New Data
Medical

Distinguishing Primary Progressive Aphasia Subtypes: New Data

Staff Reporter 3103 Views 0 Comments

The examine included in this summary was printed on medRxiv.org as a preprint and has not but been peer reviewed.

Crucial Takeaways

  • Substantial tCr and minimal glutamate+glutamine (Glx) metabolite stages in the left inferior frontal gyrus (IFG) correlate with better PPA condition severity.

  • Mind tCr ranges different amongst PPA subtypes tCr levels were being cheapest among sufferers with logopenic variant PPA (lvPPA) and maximum amongst patients with semantic variant PPA (svPPA) individuals in both the left IFG and the ideal sensorimotor cortex (SMC).

Why This Issues

  • This study is the very first assessment to report dissimilarities in mind chemistry among the PPA subtypes and associations of mind chemistry with symptom severity.

  • The results of this review suggest that tCr could serve as a biomarker to differentiate in between PPA subtypes, and both of those tCr and Glx may perhaps have utility for superior being familiar with PPA ailment mechanisms and monitoring sickness progression.

Study Layout

  • All sufferers enrolled in the analyze have been identified with PPA by expert clinicians and were ideal-handed, educated right until at least 12th quality, and had English as a 1st language.

  • People had been excluded if they have been more mature than age 90 decades, were being not premorbidly proficient spellers, had progressed to state-of-the-art levels of PPA or other dementia, had any identified comorbid neurologic situations, or if they had any contraindications for MRI scanning.

  • Three PPA subtypes have been analyzed, and a full cohort consisted of 27 clients with lvPPA (characterized by deficits in word retrieval and problem repeating text and sentences), 12 patients with svPPA (characterized by extreme deficits in single-word comprehension and naming, but preserved grammar and fluency), and 22 people with nonfluent variant PPA (nfvPPA), which is characterised by deficits in grammar and speech creation and gradual, effortful, apraxic speech, but preserved phrase comprehension and naming

  • PPA symptom severity was assessed by the FrontoTemporal Dementia Medical Dementia Rating Scale (FTD-CDR), a evaluate of general disorder severity, like language function, memory, consideration, and independence, with scores ranging from (no impairment) to 24 (serious impairment).

  • Magnetic resonance spectroscopy (MRS) was utilized to evaluate brain chemicals in vivo which includes tCr, Glx, complete N-acetyl aspartate (tNAA), and whole choline (tCho) calculated by typical limited-TE Push acquisition, and gamma-aminobutyric acid (GABA) measured by MEGA-Push acquisition. MRS data ended up analyzed utilizing the open-source analysis toolbox Osprey (v2..) within just MATLAB R2021b and statistical examination utilized R 4.. in RStudio.

Essential Results

  • Brain tCr levels differed by subtype sufferers with svPPA had larger necessarily mean tCr when compared with sufferers with lvPPA (P = .019) with no other variance in brain metabolite levels based on PPA subtype (P > .05).

  • Brain metabolite amounts differed by mind location tNAA was lower in the IFG compared to the SMC (P < .001) and tCho, tCr, and Glx were higher in the IFG compared with the SMC (P < .001). GABA levels did not differ by brain region (P = .626).

  • Worse PPA symptoms and longer disease duration were associated with higher IFG tCr levels (P = .007) and lower IFG Glx levels (P = .012).

Limitations

  • The cross-sectional approach of this study precluded assessment of metabolite levels prior to PPA onset and disease progression.

  • Because of the lack of a normal aging control group, changes in brain metabolite levels due to normal aging for PPA subtypes could not be assessed.

  • MRS methods have inherent limitations that do not allow distinction between glutamate vs glutamine signals or phosphocreatine vs creatine signals.

  • Changes in water and metabolite relaxation rates with aging and disease were not quantified and could impact metabolite quantification.

  • Patients with PPA who had difficulty remaining still in the scanner could have affected spectral quality and the ability to complete an MRI scan precluded enrollment of extremely advanced PPA cases in this cohort.

Disclosures

  • This work was supported by grants from the National Institute on Aging (K00 AG068440- 03, R00 AG062230, R01 DC014475-05, and R01 AG068881-02) and grants from the National Institute of Biomedical Imaging and Bioengineering (R01 EB016089 and P41 EB031771).

  • None of the authors disclosed any competing interests.

This is a summary of a preprint research study, “Brain total creatine differs between primary progressive aphasia (PPA) subtypes and correlates with disease severity,” written by Kathleen E. Hupfeld, Johns Hopkins University School of Medicine and Kennedy Krieger Institute, Baltimore, Maryland and colleagues on medRxiv.org, provided to you by Medscape. This study has not yet been peer reviewed. The full text of the study can be found on medRxiv.org.

For more news, follow Medscape on Facebook, Twitter, Instagram, YouTube, and LinkedIn

Credit:
Lead image: iStock/Getty Images

© 2022  WebMD, LLC

Send news tips to news@medscape.net.

Cite this: Distinguishing Primary Progressive Aphasia Subtypes: New Data – Medscape – Sep 23, 2022.

No Byline Policy

Editorial Guidelines

Corrections Policy

Leave a Reply